MYCN and neuroblastoma: In high-risk NB cells, such as those displaying the MYCN amplification that is associated with poor prognosis of NB patients [6], ligands for NK-cell-activating receptors are downregulated [7,8], thus conferring on NB cells the ability to evade the NK-cell-mediated innate immune response.